Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.


Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
Jun 2019
Historique:
received: 06 06 2018
revised: 11 10 2018
accepted: 30 10 2018
pubmed: 18 11 2018
medline: 3 9 2019
entrez: 18 11 2018
Statut: ppublish

Résumé

Gram-negative bacterial pathogens are intrinsically resistant to several antibiotics that are not able to penetrate the cell envelope barrier. The aim of this study was to identify peptides that at low concentrations induce susceptibility to these antibiotics in multidrug-resistant (MDR) Gram-negative bacterial strains of clinical relevance. Pairwise screening of 34 diverse peptides and four antibiotics (erythromycin, linezolid, rifampicin and vancomycin) with primary activity against Gram-positive bacteria identified 4 peptides that at submicromolar concentrations conferred susceptibility to rifampicin or erythromycin in Escherichia coli ATCC 25922. The identified peptides exhibited synergy with azithromycin and potentiated clindamycin in MDR E. coli ST131 and Klebsiella pneumoniae ST258. The low cytotoxicity toward eukaryotic cells (IC

Identifiants

pubmed: 30447380
pii: S0924-8579(18)30317-0
doi: 10.1016/j.ijantimicag.2018.10.025
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Peptides 0
Azithromycin 83905-01-5
Rifampin VJT6J7R4TR

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

868-872

Informations de copyright

Copyright © 2018. Published by Elsevier B.V.

Auteurs

Kristin R Baker (KR)

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark; Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre, St Kitts. Electronic address: kribake@sund.ku.dk.

Bimal Jana (B)

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark; Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre, St Kitts.

Anna Mette Hansen (AM)

Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark.

Karina Juul Vissing (KJ)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

Hanne Mørck Nielsen (HM)

Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.

Henrik Franzyk (H)

Department of Drug Design and Pharmacology, University of Copenhagen, Jagtvej 162, DK-2100 Copenhagen, Denmark. Electronic address: henrik.franzyk@sund.ku.dk.

Luca Guardabassi (L)

Department of Veterinary and Animal Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Frederiksberg, Denmark; Department of Biomedical Sciences, Ross University School of Veterinary Medicine, Basseterre, St Kitts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH